{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:09:49Z","timestamp":1792019389871,"version":"4.4.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Marine triterpene glycosides are known to exhibit significant anticancer activity. We investigated pacificusoside C and cucumariosides C\n                    <jats:sub>1<\/jats:sub>\n                    and C\n                    <jats:sub>2<\/jats:sub>\n                    isolated from a sea star\n                    <jats:italic>Solaster pacificus<\/jats:italic>\n                    in prostate cancer models with varying drug resistance and in non-cancerous cells in vitro. Cucumarioside C\n                    <jats:sub>1<\/jats:sub>\n                    showed selectivity comparable to cisplatin, whereas the other compounds were less selective. Cucumarioside C\n                    <jats:sub>1<\/jats:sub>\n                    induced apoptosis and enhanced cytotoxic effects of cisplatin, carboplatin, docetaxel, and cabazitaxel, making it a potential candidate for combination therapy. All three glycosides were active in docetaxel-resistant cells and were neither inhibitors nor substrates of P-glycoprotein, indicating P-glycoprotein-independent activity. To explore the mechanism of anticancer activity of cucumarioside C\n                    <jats:sub>1<\/jats:sub>\n                    , we performed functional kinome profiling of treated 22Rv1 cells, predicting activation of kinases involved in stress response and survival (IKK\u03b1, IKK\u03b2, IKK\u03b5), necroptosis (MLKL), metabolism (GCN2, PDK1), cytoskeletal dynamics (RHOK), mitophagy (PINK1), apoptosis and cell cycle regulation (PITSLRE), and immune modulation (COT). Notably, only MAP kinases p38 and ERK1\/2 were predicted to be specifically inhibited, that was further validated by Western blotting. These findings may potentially explain previously reported anticancer effects of cucumarioside C\n                    <jats:sub>1<\/jats:sub>\n                    and related marine glycosides. To our knowledge, this is the first study to report triterpene glycosides\u2019 effects on the kinome of cancer cells.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-12914-7","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T15:43:07Z","timestamp":1754322187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Anticancer activity of triterpene glycosides from the sea star Solaster pacificus"],"prefix":"10.1038","volume":"15","author":[{"given":"Sergey A.","family":"Dyshlovoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Hauschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Kriegs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Hoffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga Y.","family":"Burenina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja","family":"Strewinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timofey V.","family":"Malyarenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla A.","family":"Kicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia V.","family":"Ivanchina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin A.","family":"Stonik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Graefen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Bokemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunhild","family":"von Amsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"12914_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay, J. et al. Cancer statistics for the year 2020: An overview. Int. J. Cancer 149, 778\u2013789. https:\/\/doi.org\/10.1002\/ijc.33588 (2021).","journal-title":"Int. J. Cancer"},{"key":"12914_CR2","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1001\/jamaoncol.2024.0591","volume":"10","author":"M Hussain","year":"2024","unstructured":"Hussain, M. et al. Metastatic hormone-sensitive prostate cancer and combination treatment outcomes: A review. JAMA Oncol. 10, 807\u2013820. https:\/\/doi.org\/10.1001\/jamaoncol.2024.0591 (2024).","journal-title":"JAMA Oncol."},{"key":"12914_CR3","doi-asserted-by":"publisher","first-page":"100962","DOI":"10.1016\/j.drup.2023.100962","volume":"68","author":"M Cai","year":"2023","unstructured":"Cai, M. et al. Current therapy and drug resistance in metastatic castration-resistant prostate cancer. Drug Resist. Updates 68, 100962. https:\/\/doi.org\/10.1016\/j.drup.2023.100962 (2023).","journal-title":"Drug Resist. Updates"},{"key":"12914_CR4","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.neo.2020.09.002","volume":"22","author":"JE Vellky","year":"2020","unstructured":"Vellky, J. E. & Ricke, W. A. Development and prevalence of castration-resistant prostate cancer subtypes. Neoplasia 22, 566\u2013575. https:\/\/doi.org\/10.1016\/j.neo.2020.09.002 (2020).","journal-title":"Neoplasia"},{"key":"12914_CR5","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.37349\/etat.2024.00266","volume":"5","author":"N Thakur","year":"2024","unstructured":"Thakur, N. et al. Therapy resistance in prostate cancer: Mechanism, signaling and reversal strategies. Explor. Target. Antitumor. Ther. 5, 1110\u20131134. https:\/\/doi.org\/10.37349\/etat.2024.00266 (2024).","journal-title":"Explor. Target. Antitumor. Ther."},{"key":"12914_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13046-022-02255-y","volume":"41","author":"L Merkens","year":"2022","unstructured":"Merkens, L. et al. Aggressive variants of prostate cancer: Underlying mechanisms of neuroendocrine transdifferentiation. J. Exp. Clin. Cancer Res. 41, 46. https:\/\/doi.org\/10.1186\/s13046-022-02255-y (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"12914_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.32607\/20758251-2009-1-2-15-25","volume":"1","author":"VA Stonik","year":"2009","unstructured":"Stonik, V. A. Marine natural products: A way to new drugs. Acta Naturae 1, 15\u201325 (2009).","journal-title":"Acta Naturae"},{"key":"12914_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/md20120759","author":"SA Dyshlovoy","year":"2022","unstructured":"Dyshlovoy, S. A. & Honecker, F. Marine compounds and cancer: Updates 2022. Mar. Drugs. https:\/\/doi.org\/10.3390\/md20120759 (2022).","journal-title":"Mar. Drugs."},{"key":"12914_CR9","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov, A. G. et al. Natural products in drug discovery: Advances and opportunities. Nat. Rev. Drug Discov. 20, 200\u2013216. https:\/\/doi.org\/10.1038\/s41573-020-00114-z (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"12914_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fchem.2014.00077","volume":"2","author":"JI Park","year":"2014","unstructured":"Park, J. I., Bae, H. R., Kim, C. G., Stonik, V. A. & Kwak, J. Y. Relationships between chemical structures and functions of triterpene glycosides isolated from sea cucumbers. Front. Chem. 2, 77. https:\/\/doi.org\/10.3389\/fchem.2014.00077 (2014).","journal-title":"Front. Chem."},{"key":"12914_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.phymed.2017.10.019","volume":"37","author":"M-A Lacaille-Dubois","year":"2017","unstructured":"Lacaille-Dubois, M.-A. & Wagner, H. New perspectives for natural triterpene glycosides as potential adjuvants. Phytomedicine 37, 49\u201357. https:\/\/doi.org\/10.1016\/j.phymed.2017.10.019 (2017).","journal-title":"Phytomedicine"},{"key":"12914_CR12","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.3390\/md13031202","volume":"13","author":"DL Aminin","year":"2015","unstructured":"Aminin, D. L. et al. Anticancer activity of sea cucumber triterpene glycosides. Mar. Drugs 13, 1202\u20131223 (2015).","journal-title":"Mar. Drugs"},{"key":"12914_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1080\/10286020500208626","volume":"8","author":"YC Zhan","year":"2006","unstructured":"Zhan, Y. C. et al. A new triterpene glycoside from Asterias rollentoni. J. Asian Nat. Prod. Res. 8, 631\u2013636. https:\/\/doi.org\/10.1080\/10286020500208626 (2006).","journal-title":"J. Asian Nat. Prod. Res."},{"key":"12914_CR14","doi-asserted-by":"publisher","DOI":"10.1177\/1934578x19858522","author":"NV Ivanchina","year":"2019","unstructured":"Ivanchina, N. V., Kalinovsky, A. I., Malyarenko, T. V., Kicha, A. A. & Dmitrenok, P. S. A. Holothurian triterpene glycoside holothurin A2 (= echinoside A) isolated from the starfish Choriaster granulatus. Nat. Prod. Commun. https:\/\/doi.org\/10.1177\/1934578x19858522 (2019).","journal-title":"Nat. Prod. Commun."},{"key":"12914_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/biom11030427","author":"TV Malyarenko","year":"2021","unstructured":"Malyarenko, T. V. et al. New triterpene glycosides from the far eastern starfish Solaster pacificus and their biological activity. Biomolecules https:\/\/doi.org\/10.3390\/biom11030427 (2021).","journal-title":"Biomolecules"},{"key":"12914_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/md20030216","author":"TV Malyarenko","year":"2022","unstructured":"Malyarenko, T. V. et al. In Vitro anticancer and cancer-preventive activity of new triterpene glycosides from the far eastern starfish Solaster pacificus. Mar. Drugs https:\/\/doi.org\/10.3390\/md20030216 (2022).","journal-title":"Mar. Drugs"},{"key":"12914_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/md22010019","volume":"22","author":"TV Malyarenko","year":"2024","unstructured":"Malyarenko, T. V. et al. New Rare triterpene glycosides from pacific sun star, Solaster pacificus, and their anticancer activity. Mar. Drugs 22, 19 (2024).","journal-title":"Mar. Drugs"},{"key":"12914_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/md18120584","author":"VA Stonik","year":"2020","unstructured":"Stonik, V. A., Kicha, A. A., Malyarenko, T. V. & Ivanchina, N. V. Asterosaponins: Structures, taxonomic distribution. Biog. Biol. Act. Mar. Drugs https:\/\/doi.org\/10.3390\/md18120584 (2020).","journal-title":"Biog. Biol. Act. Mar. Drugs"},{"key":"12914_CR19","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.3390\/md12084274","volume":"12","author":"J Wang","year":"2014","unstructured":"Wang, J., Han, H., Chen, X., Yi, Y. & Sun, H. Cytotoxic and apoptosis-inducing activity of triterpene glycosides from Holothuria scabra and Cucumaria frondosa against HepG2 cells. Mar. Drugs 12, 4274\u20134290. https:\/\/doi.org\/10.3390\/md12084274 (2014).","journal-title":"Mar. Drugs"},{"key":"12914_CR20","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.3390\/md13031202","volume":"13","author":"DL Aminin","year":"2015","unstructured":"Aminin, D. L. et al. Anticancer activity of sea cucumber triterpene glycosides. Mar. Drugs 13, 1202\u20131223. https:\/\/doi.org\/10.3390\/md13031202 (2015).","journal-title":"Mar. Drugs"},{"key":"12914_CR21","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s10637-017-0505-5","volume":"35","author":"TL Wargasetia","year":"2017","unstructured":"Wargasetia, T. L. & Widodo,. Mechanisms of cancer cell killing by sea cucumber-derived compounds. Invest. New Drugs 35, 820\u2013826. https:\/\/doi.org\/10.1007\/s10637-017-0505-5 (2017).","journal-title":"Invest. New Drugs"},{"key":"12914_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/md15100317","author":"MAM Mondol","year":"2017","unstructured":"Mondol, M. A. M., Shin, H. J., Rahman, M. A. & Islam, M. T. Sea cucumber glycosides: Chemical structures, producing species and important biological properties. Mar. Drugs. https:\/\/doi.org\/10.3390\/md15100317 (2017).","journal-title":"Mar. Drugs."},{"key":"12914_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/md21120602","author":"AS Silchenko","year":"2023","unstructured":"Silchenko, A. S. et al. Sulfated triterpene glycosides from the far eastern sea cucumber Cucumaria djakonovi: Djakonoviosides C(1), D(1), E(1), and F(1); cytotoxicity against human breast cancer cell lines quantitative structure-activity relationships. Mar. Drugs https:\/\/doi.org\/10.3390\/md21120602 (2023).","journal-title":"Mar. Drugs"},{"key":"12914_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/md22010020","volume":"22","author":"ES Menchinskaya","year":"2024","unstructured":"Menchinskaya, E. S. et al. Anticancer activity of the marine triterpene glycoside cucumarioside A2-2 in human prostate cancer cells. Mar. Drugs 22, 20 (2024).","journal-title":"Mar. Drugs"},{"key":"12914_CR25","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/annonc\/mdp335","volume":"21","author":"M Li","year":"2010","unstructured":"Li, M. et al. Echinoside A, a new marine-derived anticancer saponin, targets topoisomerase2\u03b1 by unique interference with its DNA binding and catalytic cycle. Ann. Oncol. 21, 597\u2013607. https:\/\/doi.org\/10.1093\/annonc\/mdp335 (2010).","journal-title":"Ann. Oncol."},{"key":"12914_CR26","doi-asserted-by":"publisher","DOI":"10.1177\/1934578x221105369","author":"LT Vien","year":"2022","unstructured":"Vien, L. T. et al. Triterpene tetraglycosides from Stichopus herrmanni semper, 1868. Nat. Prod. Commun. 17. https:\/\/doi.org\/10.1177\/1934578x221105369 (2022).","journal-title":"Nat. Prod. Commun."},{"key":"12914_CR27","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1002\/ijc.29977","volume":"138","author":"SA Dyshlovoy","year":"2016","unstructured":"Dyshlovoy, S. A. et al. The marine triterpene glycoside frondoside a exhibits activity in vitro and in vivo in prostate cancer. Int. J. Cancer 138, 2450\u20132465. https:\/\/doi.org\/10.1002\/ijc.29977 (2016).","journal-title":"Int. J. Cancer"},{"key":"12914_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1469392","author":"M Jiang","year":"2025","unstructured":"Jiang, M. et al. Recent advances in the anti-tumor activities of saponins through cholesterol regulation. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2024.1469392 (2025).","journal-title":"Front. Pharmacol."},{"key":"12914_CR29","doi-asserted-by":"publisher","first-page":"7886","DOI":"10.3390\/molecules18077886","volume":"18","author":"Y-X Li","year":"2013","unstructured":"Li, Y.-X., Himaya, S. W. A. & Kim, S.-K. Triterpenoids of marine origin as anti-cancer agents. Molecules 18, 7886\u20137909 (2013).","journal-title":"Molecules"},{"key":"12914_CR30","doi-asserted-by":"publisher","first-page":"R49","DOI":"10.1530\/erc-12-0401","volume":"20","author":"N Sampson","year":"2013","unstructured":"Sampson, N., Neuwirt, H., Puhr, M., Klocker, H. & Eder, I. E. In vitro model systems to study androgen receptor signaling in prostate cancer. Endocr. Relat. Cancer 20, R49\u2013R64. https:\/\/doi.org\/10.1530\/erc-12-0401 (2013).","journal-title":"Endocr. Relat. Cancer"},{"key":"12914_CR31","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1056\/NEJMe1409306","volume":"371","author":"PS Nelson","year":"2014","unstructured":"Nelson, P. S. Targeting the androgen receptor in prostate cancer\u2014A resilient foe. New Engl. J. Med. 371, 1067\u20131069. https:\/\/doi.org\/10.1056\/NEJMe1409306 (2014).","journal-title":"New Engl. J. Med."},{"key":"12914_CR32","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.ajpath.2012.08.011","volume":"181","author":"M Puhr","year":"2012","unstructured":"Puhr, M. et al. Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of mir-200c and mir-205. Am. J. Pathol. 181, 2188\u20132201. https:\/\/doi.org\/10.1016\/j.ajpath.2012.08.011 (2012).","journal-title":"Am. J. Pathol."},{"key":"12914_CR33","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s00120-024-02511-3","volume":"64","author":"G von Amsberg","year":"2025","unstructured":"von Amsberg, G., Dyshlovoy, S. & Kaune, M. Aggressive variant prostate cancer and transdifferentiated neuroendocrine prostate cancer: From diagnosis to therapy. Urologie 64, 246\u2013255. https:\/\/doi.org\/10.1007\/s00120-024-02511-3 (2025).","journal-title":"Urologie"},{"key":"12914_CR34","doi-asserted-by":"publisher","first-page":"13570","DOI":"10.1038\/s41598-022-17447-x","volume":"12","author":"SA Dyshlovoy","year":"2022","unstructured":"Dyshlovoy, S. A. et al. New diterpenes from the marine sponge Spongionella sp. overcome drug resistance in prostate cancer by inhibition of P-glycoprotein. Sci. Rep. 12, 13570. https:\/\/doi.org\/10.1038\/s41598-022-17447-x (2022).","journal-title":"Sci. Rep."},{"key":"12914_CR35","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1124\/dmd.113.056176","volume":"42","author":"R Callaghan","year":"2014","unstructured":"Callaghan, R., Luk, F. & Bebawy, M. Inhibition of the multidrug resistance P-glycoprotein: Time for a change of strategy?. Drug Metab. Dispos. 42, 623\u2013631. https:\/\/doi.org\/10.1124\/dmd.113.056176 (2014).","journal-title":"Drug Metab. Dispos."},{"key":"12914_CR36","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1476-4598-10-126","volume":"10","author":"AJ O'Neill","year":"2011","unstructured":"O\u2019Neill, A. J. et al. Characterisation and manipulation of docetaxel resistant prostate cancer cell lines. Mol. Cancer 10, 126\u2013126. https:\/\/doi.org\/10.1186\/1476-4598-10-126 (2011).","journal-title":"Mol. Cancer"},{"key":"12914_CR37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1124\/dmd.115.067785","volume":"44","author":"LD Weidner","year":"2016","unstructured":"Weidner, L. D. et al. Tariquidar is an inhibitor and not a substrate of human and mouse p-glycoprotein. Drug Metab. Dispos. 44, 275. https:\/\/doi.org\/10.1124\/dmd.115.067785 (2016).","journal-title":"Drug Metab. Dispos."},{"key":"12914_CR38","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/md20100597","volume":"20","author":"SA Dyshlovoy","year":"2022","unstructured":"Dyshlovoy, S. A. et al. Cytotoxic N-methylpretrichodermamide B reveals anticancer activity and inhibits p-glycoprotein in drug-resistant prostate cancer cells. Mar. Drugs 20, 597 (2022).","journal-title":"Mar. Drugs"},{"key":"12914_CR39","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1158\/1078-0432.Ccr-10-1725","volume":"17","author":"RJ Kelly","year":"2011","unstructured":"Kelly, R. J. et al. A pharmacodynamic study of docetaxel in combination with the p-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer. Clin. Cancer Res. 17, 569\u2013580. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-10-1725 (2011).","journal-title":"Clin. Cancer Res."},{"key":"12914_CR40","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","volume":"26","author":"AS Dhillon","year":"2007","unstructured":"Dhillon, A. S., Hagan, S., Rath, O. & Kolch, W. MAP kinase signalling pathways in cancer. Oncogene 26, 3279\u20133290. https:\/\/doi.org\/10.1038\/sj.onc.1210421 (2007).","journal-title":"Oncogene"},{"key":"12914_CR41","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41573-021-00195-4","volume":"20","author":"P Cohen","year":"2021","unstructured":"Cohen, P., Cross, D. & J\u00e4nne, P. A. Kinase drug discovery 20 years after imatinib: Progress and future directions. Nat. Rev. Drug Discov. 20, 551\u2013569. https:\/\/doi.org\/10.1038\/s41573-021-00195-4 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"12914_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21061913","author":"A Mart\u00ednez-Lim\u00f3n","year":"2020","unstructured":"Mart\u00ednez-Lim\u00f3n, A., Joaquin, M., Caballero, M., Posas, F. & de Nadal, E. The p38 pathway: From biology to cancer therapy. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21061913 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"12914_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101618","author":"C Braicu","year":"2019","unstructured":"Braicu, C. et al. A comprehensive review on MAPK: A promising therapeutic target in cancer. Cancers https:\/\/doi.org\/10.3390\/cancers11101618 (2019).","journal-title":"Cancers"},{"key":"12914_CR44","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.21873\/anticanres.15167","volume":"41","author":"H Watanabe","year":"2021","unstructured":"Watanabe, H. et al. Molecular mechanism mediating cytotoxic activity of cabazitaxel in docetaxel-resistant human prostate cancer cells. Anticancer Res. 41, 3753. https:\/\/doi.org\/10.21873\/anticanres.15167 (2021).","journal-title":"Anticancer Res."},{"key":"12914_CR45","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1111\/cas.13729","volume":"109","author":"H Hongo","year":"2018","unstructured":"Hongo, H., Kosaka, T. & Oya, M. Analysis of cabazitaxel-resistant mechanism in human castration-resistant prostate cancer. Cancer Sci. 109, 2937\u20132945. https:\/\/doi.org\/10.1111\/cas.13729 (2018).","journal-title":"Cancer Sci."},{"key":"12914_CR46","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3892\/ol.2024.14719","volume":"28","author":"A Cui","year":"2024","unstructured":"Cui, A. et al. Steroidal saponins: Natural compounds with the potential to reverse tumor drug resistance (review). Oncol. Lett. 28, 585. https:\/\/doi.org\/10.3892\/ol.2024.14719 (2024).","journal-title":"Oncol. Lett."},{"key":"12914_CR47","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1476-4598-12-86","volume":"12","author":"B Hoesel","year":"2013","unstructured":"Hoesel, B. & Schmid, J. A. The complexity of NF-\u03baB signaling in inflammation and cancer. Mol. Cancer 12, 86. https:\/\/doi.org\/10.1186\/1476-4598-12-86 (2013).","journal-title":"Mol. Cancer"},{"key":"12914_CR48","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1158\/1535-7163.Mct-15-0999","volume":"15","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. et al. Targeting I\u03baB Kinase \u03b2\/NF-\u03baB signaling in human prostate cancer by a novel i\u03baB kinase \u03b2 inhibitor cmpdA. Mol. Cancer Ther. 15, 1504\u20131514. https:\/\/doi.org\/10.1158\/1535-7163.Mct-15-0999 (2016).","journal-title":"Mol. Cancer Ther."},{"key":"12914_CR49","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s44321-023-00011-z","volume":"16","author":"X Wu","year":"2024","unstructured":"Wu, X., Nagy, L. E. & Gautheron, J. Mediators of necroptosis: From cell death to metabolic regulation. EMBO Mol. Med. 16, 219\u2013237. https:\/\/doi.org\/10.1038\/s44321-023-00011-z (2024).","journal-title":"EMBO Mol. Med."},{"key":"12914_CR50","doi-asserted-by":"publisher","first-page":"35314","DOI":"10.1074\/jbc.M202179200","volume":"277","author":"S Zhang","year":"2002","unstructured":"Zhang, S. et al. Interaction of p58PITSLRE, a G2\/M-specific protein kinase, with cyclin D3*. J. Biol. Chem. 277, 35314\u201335322. https:\/\/doi.org\/10.1074\/jbc.M202179200 (2002).","journal-title":"J. Biol. Chem."},{"key":"12914_CR51","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cmet.2007.01.001","volume":"5","author":"F Guo","year":"2007","unstructured":"Guo, F. & Cavener, D. R. The GCN2 eIF2\u03b1 kinase regulates fatty-acid homeostasis in the liver during deprivation of an essential amino acid. Cell Metab. 5, 103\u2013114. https:\/\/doi.org\/10.1016\/j.cmet.2007.01.001 (2007).","journal-title":"Cell Metab."},{"key":"12914_CR52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/82_2010_43","volume":"346","author":"JR Bayascas","year":"2010","unstructured":"Bayascas, J. R. PDK1: The major transducer of PI 3-kinase actions. Curr. Top Microbiol. Immunol. 346, 9\u201329. https:\/\/doi.org\/10.1007\/82_2010_43 (2010).","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"12914_CR53","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/cm.20472","volume":"67","author":"M Amano","year":"2010","unstructured":"Amano, M., Nakayama, M. & Kaibuchi, K. Rho-kinase\/ROCK: A key regulator of the cytoskeleton and cell polarity. Cytoskeleton 67, 545\u2013554. https:\/\/doi.org\/10.1002\/cm.20472 (2010).","journal-title":"Cytoskeleton"},{"key":"12914_CR54","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/s41556-024-01513-9","volume":"26","author":"DP Narendra","year":"2024","unstructured":"Narendra, D. P. & Youle, R. J. The role of PINK1-parkin in mitochondrial quality control. Nat. Cell Biol. 26, 1639\u20131651. https:\/\/doi.org\/10.1038\/s41556-024-01513-9 (2024).","journal-title":"Nat. Cell Biol."},{"key":"12914_CR55","doi-asserted-by":"publisher","first-page":"674613","DOI":"10.3389\/fgene.2021.674613","volume":"12","author":"J Hao","year":"2021","unstructured":"Hao, J. et al. Effect of MAP3K8 on prognosis and tumor-related inflammation in renal clear cell carcinoma. Front. Genet. 12, 674613. https:\/\/doi.org\/10.3389\/fgene.2021.674613 (2021).","journal-title":"Front. Genet."},{"key":"12914_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mc.20160","volume":"45","author":"H Mizuno","year":"2006","unstructured":"Mizuno, H., Cho, Y. Y., Ma, W. Y., Bode, A. M. & Dong, Z. Effects of MAP kinase inhibitors on epidermal growth factor-induced neoplastic transformation of human keratinocytes. Mol. Carcinog. 45, 1\u20139. https:\/\/doi.org\/10.1002\/mc.20160 (2006).","journal-title":"Mol. Carcinog."},{"key":"12914_CR57","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1158\/1541-7786.Mcr-13-0029-t","volume":"11","author":"K Hatano","year":"2013","unstructured":"Hatano, K. et al. Residual prostate cancer cells after docetaxel therapy increase the tumorigenic potential via constitutive signaling of CXCR4, ERK1\/2 and c-Myc. Mol. Cancer Res. 11, 1088\u20131100. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-13-0029-t (2013).","journal-title":"Mol. Cancer Res."},{"key":"12914_CR58","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/md18050251","volume":"18","author":"SA Dyshlovoy","year":"2020","unstructured":"Dyshlovoy, S. A. et al. inspired by sea urchins: Warburg effect mediated selectivity of novel synthetic non-glycoside 1,4-naphthoquinone-6s-glucose conjugates in prostate cancer. Mar. Drugs 18, 251 (2020).","journal-title":"Mar. Drugs"},{"key":"12914_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/md18120609","author":"SA Dyshlovoy","year":"2020","unstructured":"Dyshlovoy, S. A. et al. Efficacy and mechanism of action of marine alkaloid 3,10-dibromofascaplysin in drug-resistant prostate cancer cells. Mar. Drugs. https:\/\/doi.org\/10.3390\/md18120609 (2020).","journal-title":"Mar. Drugs."},{"key":"12914_CR60","doi-asserted-by":"publisher","first-page":"W739","DOI":"10.1093\/nar\/gkac382","volume":"50","author":"A Ianevski","year":"2022","unstructured":"Ianevski, A., Giri, A. K. & Aittokallio, T. SynergyFinder 3.0: An interactive analysis and consensus interpretation of multi-drug synergies across multiple samples. Nucleic Acid. Res. 50, W739\u2013W743. https:\/\/doi.org\/10.1093\/nar\/gkac382 (2022).","journal-title":"Nucleic Acid. Res."},{"key":"12914_CR61","doi-asserted-by":"publisher","first-page":"020","DOI":"10.1038\/s41598-020-69751-z","volume":"10","author":"SA Dyshlovoy","year":"2020","unstructured":"Dyshlovoy, S. A. et al. Marine alkaloid monanchoxymycalin C: A new specific activator of JNK1\/2 kinase with anticancer properties. Sci. Rep. 10, 020\u201369751 (2020).","journal-title":"Sci. Rep."},{"key":"12914_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11111690","author":"AS Dyshlovoy","year":"2019","unstructured":"Dyshlovoy, A. S. et al. Successful targeting of the Warburg effect in prostate cancer by glucose-conjugated 1,4-naphthoquinones. Cancers https:\/\/doi.org\/10.3390\/cancers11111690 (2019).","journal-title":"Cancers"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12914-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12914-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12914-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T13:40:47Z","timestamp":1757338847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12914-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12914"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12914-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6590419\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"4 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"28410"}}